Genetic Signatures (ASX:GSS) Revenue : A$14.56 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Revenue?

Genetic Signatures's revenue for the six months ended in Dec. 2023 was A$3.60 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$14.56 Mil. Genetic Signatures's Revenue per Share for the six months ended in Dec. 2023 was A$0.03. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.10.

Warning Sign:

Genetic Signatures Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Genetic Signatures was -39.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 18.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 49.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 9 years, Genetic Signatures's highest 3-Year average Revenue per Share Growth Rate was 91.60% per year. The lowest was 10.50% per year. And the median was 42.40% per year.

Genetic Signatures Revenue Historical Data

The historical data trend for Genetic Signatures's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Revenue Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Revenue

Get a 7-Day Free Trial

4.87

11.26

28.28

35.42

21.36

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Revenue	Get a 7-Day Free Trial													21.84	13.58	10.41	10.96	3.60

Competitive Comparison of Genetic Signatures's Revenue

For the Diagnostics & Research subindustry, Genetic Signatures's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Revenue distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's Revenue falls into.

Genetic Signatures Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$14.56 Mil.

Genetic Signatures (ASX:GSS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Genetic Signatures Revenue Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.